{"id":"9aa7ff25-6c2d-5cbf-acd8-7e8e14252727","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-nac-lname-block","predicate":"abolishes_in_model","statement":"Administration of either N-acetylcysteine or L-NAME before treatment suppressed angiogenesis and muscle regeneration even after hyperbaric oxygen.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"7b9d02b5-8bed-5e6c-a33a-ffa436764443","mechanism_event_label":"Mopping up the reactive species, or blocking nitric oxide production, cancels the benefit.","subject":{"id":"b5fa7a22-e5a7-58d9-9e39-91a611aa431e","slug":"n-acetylcysteine","display_name":"N-Acetyl-L-cysteine","entity_type_key":"small_molecule"},"object":{"id":"19d528a9-f680-5ab2-9007-3e40c92781e9","slug":"muscle-regeneration","display_name":"Skeletal muscle regeneration after contusion","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"7b9d02b5-8bed-5e6c-a33a-ffa436764443","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-nac-lname-block-event","event_type":"biochemical_relationship","label":"Mopping up the reactive species, or blocking nitric oxide production, cancels the benefit.","description":"Administration of either N-acetylcysteine or L-NAME before treatment suppressed angiogenesis and muscle regeneration even after hyperbaric oxygen.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"0aae6a8b-3190-58a0-bc99-b93010302f90","slug":"l-name","display_name":"N-omega-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor","entity_type_key":"small_molecule"},"role":"co_inhibitor","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b51f3150-efc0-5413-a47a-01d094d248b7","slug":"reactive-oxygen-species","display_name":"Reactive oxygen species","entity_type_key":"chemical_species"},"role":"scavenged_signal","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"9dbb6cfa-50e1-5ff1-8b7e-6d747bf9ad03","slug":"angiogenesis","display_name":"Angiogenesis / new blood vessel formation","entity_type_key":"cellular_process"},"role":"blocked_process","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"b5fa7a22-e5a7-58d9-9e39-91a611aa431e","slug":"n-acetylcysteine","display_name":"N-Acetyl-L-cysteine","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"19d528a9-f680-5ab2-9007-3e40c92781e9","slug":"muscle-regeneration","display_name":"Skeletal muscle regeneration after contusion","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/hbot-research/32066777.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\", \"start_char\": 0, \"end_char\": 1357, \"text_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"2.5 ATA 100% oxygen for 120 minutes daily for 5 consecutive days","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Both inhibitors were given before treatment, which is what makes the requirement claim interpretable. The exposure is a therapy-like protocol, unlike the extreme-pressure studies recorded elsewhere here.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Mopping up the reactive species, or blocking nitric oxide production, cancels the benefit.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Skeletal muscle","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"35800ed9-06f5-53ed-a1ee-d1469827892b","evidence_kind":"source_excerpt","locator":"Lines 699-710","start_line":699,"end_line":710,"excerpt":"### hbot-nac-lname-block\nAdministration of either N-acetylcysteine or L-NAME before treatment suppressed angiogenesis and muscle regeneration even after hyperbaric oxygen.\nCondition category: machinery_impairment\nnutrient_topic: Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.\nplain_language: Mopping up the reactive species, or blocking nitric oxide production, cancels the benefit.\norganism: Rat\ntissue_or_cell_type: Skeletal muscle\nexperimental_model: Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor\nlimitations: Both inhibitors were given before treatment, which is what makes the requirement claim interpretable. The exposure is a therapy-like protocol, unlike the extreme-pressure studies recorded elsewhere here.\nexposure: 2.5 ATA 100% oxygen for 120 minutes daily for 5 consecutive days\nevidence_span: {\"source_cache\": \"artifacts/hbot-research/32066777.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\", \"start_char\": 0, \"end_char\": 1357, \"text_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\"}\n[hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","model_system":"Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dbf39b48-c95e-5291-b404-349ffbc4488f","stable_key":"import-488ea171-36b8-5ef6-b5d3-98563980fdbf","title":"Hyperbaric oxygen: the exposure, its reactive species, the signals they carry, and the nutrient-dependent enzymes that handle them (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"fb2443321804010d82c6b96ab61cc51b4b6628ddbb15751cb0e90b491606e79c","revision_id":"bb699ea5-b492-5728-b22c-48f0842a8ac9","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}